SCHEDULE 13G/A

ELEVATION ONCOLOGY INC

Common Stock, par value $0.0001 per share · CUSIP: 28623U101

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• BIOTECHNOLOGY VALUE FUND L P

  Shares: 2,374,712.00 · Class: 3.9%

• BVF I GP LLC

  Shares: 2,374,712.00 · Class: 3.9%

• BIOTECHNOLOGY VALUE FUND II LP

  Shares: 1,826,364.00 · Class: 3.0%

• BVF II GP LLC

  Shares: 1,826,364.00 · Class: 3.0%

• Biotechnology Value Trading Fund OS LP

  Shares: 210,388.00 · Class: 0.4%

• BVF Partners OS Ltd.

  Shares: 210,388.00 · Class: 0.4%

• BVF GP HOLDINGS LLC

  Shares: 4,201,076.00 · Class: 6.6%

• BVF PARTNERS L P/IL

  Shares: 4,440,000.00 · Class: 7.0%

• BVF INC/IL

  Shares: 4,440,000.00 · Class: 7.0%

• LAMPERT MARK N

  Shares: 4,440,000.00 · Class: 7.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.